Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-284823
Filing Date
2015-08-10
Accepted
2015-08-10 16:05:25
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d939843d10q.htm 10-Q 437356
2 EX-31.1 d939843dex311.htm EX-31.1 9020
3 EX-31.2 d939843dex312.htm EX-31.2 9006
4 EX-32.1 d939843dex321.htm EX-32.1 4777
11 GRAPHIC g939843fs_new.jpg GRAPHIC 10323
  Complete submission text file 0001193125-15-284823.txt   3045675

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rxdx-20150630.xml EX-101.INS 501792
6 XBRL TAXONOMY EXTENSION SCHEMA rxdx-20150630.xsd EX-101.SCH 33640
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rxdx-20150630_cal.xml EX-101.CAL 48815
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rxdx-20150630_def.xml EX-101.DEF 114071
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rxdx-20150630_lab.xml EX-101.LAB 327440
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rxdx-20150630_pre.xml EX-101.PRE 224927
Mailing Address 11095 FLINTKOTE AVE. SUITE D SAN DIEGO CA 92121
Business Address 11095 FLINTKOTE AVE. SUITE D SAN DIEGO CA 92121 (858) 255-5959
Ignyta, Inc. (Filer) CIK: 0001557421 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36344 | Film No.: 151040732
SIC: 2834 Pharmaceutical Preparations